For long-term investors, this could be an excellent stock to buy and hold. Keith Speights (Pfizer): Pfizer has been a big loser in recent years, although it has eked out a meager gain in 2024. However ...

Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

New, more expensive migraine drugs are no more effective against the throbbing headaches than traditional painkillers, and ...

The latest strain of the COVID-19 virus, XEC, is circulating across the country. The new variant has been reported in at ...

XEC is also an offshoot of omicron, the widely spread variant that formed in 2021. According to experts, it has some of omicron’s features, too — like less severe symptoms and easy transmissibility.

Jackson County Health Department (JCHD) is now providing flu vaccinations by appointment. An annual flu vaccination is ...

Pfizer (PFE) closed the latest trading day at $29.42, indicating a -0.83% change from the previous session's end. This move lagged the S&P 500's daily loss of 0.19%. Meanwhile, the Dow gained 0.09%, ...

Shares of Pfizer Inc. PFE dropped 0.81% to $29.42 Friday, on what proved to be an all-around mixed trading session for the ...

Warning: COVID Vaccines Linked to Cancer Risks, Experts Say** In a shocking revelation that could alter the narrative surrounding COVID-19 vaccinations, a prominent molecular vi ...

Este químico de procesos contribuyó al escalado de la producción de un componente clave de un antiviral contra COVID-19 ...

We’re still asking people with COVID to jump through far too many hoops to get their hands on Pfizer Inc.’s Paxlovid.” ...